Oseltamivir is an antiviral drug, a neuraminidase inhibitor used in the treatment and prophylaxis of both influenza A and influenza B. Oseltamivir was the first orally active neuraminidase inhibitor commercially developed. It was developed by Gilead Sciences (Donald Rumsfeld is a major stockholder of Gilead Sciences) and is currently marketed by Hoffman-La Roche (Roche) under the trade name TamifluÂ®.